Paul B Manning 13D and 13G filings for Taysha Gene Therapies, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-06-03 9:54 pm Purchase |
2025-05-30 | 13D | Taysha Gene Therapies, Inc. TSHA |
Paul B Manning | 25,601,111 9.800% |
2,124,778 (+9.05%) |
Filing |
| 2023-08-21 4:01 pm Purchase |
2023-08-16 | 13D | Taysha Gene Therapies, Inc. TSHA |
Paul B Manning | 23,476,333 12.600% |
16,486,472 (+235.86%) |
Filing |
| 2022-11-02 4:02 pm Purchase |
2022-10-31 | 13D | Taysha Gene Therapies, Inc. TSHA |
Paul B Manning | 6,989,861 11.200% |
1,694,554 (+32.00%) |
Filing |
| 2020-10-05 5:26 pm Purchase |
2020-09-23 | 13D | Taysha Gene Therapies, Inc. TSHA |
Paul B Manning | 5,295,307 14.300% |
5,295,307 (New Position) |
Filing |